资本聚三湘 楚光耀新程--2025年湖南辖区上市公司集体接待日暨半年度业绩说明会9月19日在全景网举 行。尔康制药（300267）董事会秘书顾吉顺介绍，公司继续积极践行国家"一带一路"倡议，推动国际化 战略布局，结合非洲资源禀赋与中国产业优势，已提出以尼日利亚、坦桑尼亚为支点，构建"资源开发 +产业赋能+技术输出"三位一体的非洲市场开拓计划，主要如下：1、尼日利亚锂矿资源开发：依托公 司已建成投产的锂矿选矿厂，加强资源开发，创新经营模式，打造新能源上游供应链；2、坦桑尼亚产 业赋能：充分利用当地丰富的资源，引入国内先进生产技术与设备，建设现代化加工基地，生产特色产 品丰富当地市场或返销国内，缓解国内供需压力；3、非洲本土化医药生产布局：设立符合GMP 标准的 药品生产基地，输出中国制剂技术及优质药品，服务非洲基层医疗需求。通过本地化用工、技术支持、 基建投资等方式深化中非合作，形成"资源互补+产业协同+民生改善"的可持续发展模式。 更多详情，请点击：https://rs.p5w.net/html/175679135777130.shtml ...

Core Viewpoint - The company plans to repurchase its shares to maintain company value and protect shareholder interests, with a total repurchase fund of no less than RMB 400 million and no more than RMB 500 million, at a maximum price of RMB 17.75 per share [2][4][5]. Summary by Relevant Sections Repurchase Plan Overview - The purpose of the share repurchase is based on confidence in future development and recognition of intrinsic value, aiming to enhance investor confidence and promote long-term healthy development [4]. - The repurchase complies with relevant regulations and is necessary to maintain company value and shareholder rights, as the stock price is below the latest net asset value per share [5][6]. Financial Details - The total amount for the repurchase is set between RMB 400 million and RMB 500 million, with an estimated repurchase quantity of approximately 22,535,212 to 28,169,014 shares, representing 2.46% to 3.08% of the current total share capital [8][15]. - The funding sources for the repurchase include the company's own funds and a special loan from a financial institution, with a loan amount not exceeding RMB 400 million [9][16]. Implementation Timeline - The implementation period for the repurchase is three months from the board's approval date, with provisions for extension if significant matters arise [10][12]. - The repurchase can be completed early if the minimum or maximum funding limits are reached [11][13]. Shareholder and Management Commitments - As of the announcement date, there are no plans for share reductions by major shareholders or management [2][17]. - The board has committed to ensuring that the repurchase will not harm the company's debt repayment ability or ongoing operations [16]. Regulatory Compliance and Reporting - The company has established a dedicated securities account for the repurchase and will adhere to disclosure requirements throughout the process [22][25]. - Regular updates on the repurchase progress will be provided, including significant changes in shareholding [22].